Cerebrospinal Fluid Lactate as a Differential Biomarker for Bacterial and Viral Meningitis.

Meningitis is a critical public health problem demanding immediate diagnosis and effective treatment due to high mortality rates. Cerebrospinal Fluid (CSF) lactate concentration is a promising test to distinguish bacterial from viral meningitis. This study aimed to assess the performance and usefulness of CSF lactate as a biomarker to differentiate between bacterial and viral meningitis, and to determine its optimal level to differentiate between them. This prospective study included 50 patients, presented to Abbassia Fever Hospital with clinical findings consistent with meningitis. Patients were divided into two groups: Group1 included 30 patients with bacterial meningitis. Group 2 included 20 patients with viral meningitis. CSF lactate and other conventional CSF parameters were recorded. For CSF culture, Streptococcus pneumoniae was identified in 53.3% of the bacterial meningitis group. The polymerase chain reaction (PCR) indicated that S. pneumoniae was present in 26/50 (52%) and 3/50 (6%) patients were PCR negative. Among bacterial meningitis patients, S. pneumoniae was the most pervasive organism 26/30 (86.7%). The mean CSF lactate level was 9.3 mmol/l ±5.0 (2.2-17.6). There was a statistically significant strong agreement (Kappa=0.957) between types of meningitis diagnosed by PCR, culture, and CSF lactate at cutoff level of 7.2 mmol/L. This cutoff value was the best to differentiate between bacterial and viral meningitis. The validity of CSF lactate as a differentiating tool showed sensitivity, specificity, positive predictive value, and negative predictive value of 93.3%, 100%, 100%, and 90.9%, respectively. In conclusion, CSF lactate could be a valuable, sensitive, specific, and rapid marker for identifying the most dangerous bacterial causes of CNS infection, especially S. pneumoniae. CSF lactate can be routinely used as an early biochemical warning marker and a useful point-of-care test. CSF lactate at cutoff level of >7.2 mmol/L can accurately detect S. pneumoniae, the most prevalent organism in Egypt.

Fabrication of facile polymeric nanocomposites based on chitosan-gr-P2-aminothiophenol for biomedical applications.

Cancer is an abnormal growth of cells due to the uncontrolled division of the cells and it is the second leading cause of death globally. Immune system malfunction, inflammatory diseases, microbial infection, and oxidative damage are other causes for death. This prompted us to search for non-traditional materials that can be used as anti-cancer, anti-microbial, anti-oxidant and anti-inflammatory agents. Chitosan as a non-toxic, biodegradable, biopolymer with powerful biological activity was grafted with acidified 2-aminothiophenol (2-ATH) using aqueous chemical oxidative copolymerization in presence of ammonium persulphate (APS) as an oxidant at room temperature. The prepared polymeric samples were assembled on silver nanoparticles (AgNPs). The prepared polymeric structure nano-composites were verified by infrared, ultraviolet-visible spectroscopy, X-ray diffraction, thermogravimetric analysis scanning electron microscopy and transmission electron microscopy. The prepared polymeric samples and their composites with AgNPs were screened for their biological activities as anti-cancer properties, anti-microbial, anti-oxidant and anti-inflammatory. The obtained data reveal that chitosan-gr-poly (2-aminothiophenol) (chitosan-gr-p2-ATH) has the most potent anti-oxidant and anti-cancer effects against HepG2 while the composites of p2-ATH with AgNPs and chitosan-gr-p2-ATH with AgNPs have the most potent anti-inflammatory properties.

Synthesis and biological evaluation of some nitrogen containing steroidal heterocycles.

epi-Androsterone 1 was converted into its hydrazone derivative through the reaction with hydrazine hydrate 80%. Hydrazonoandrostane derivative 2b reacted with hydrazonoyl halides in the presence of K(2)CO(3) forming the corresponding hydrazopyridazinoandrostane derivatives 6a-d. The 3ß-acetyl-17-hydrazonoandrostane derivative 2b reacted with a halogen reagent, benzoyl chloride, to form the non-cyclic 16-benzoylated hydrazone 9. On the other hand, compound 2b produced the corresponding pyridazinoandrostane derivatives 11 and 12 via its reaction with phenacyl bromide and chloroacetone respectively. Reaction of the hydrazono derivative 2b with benzaldehyde in the presence of acetic acid drops led to the formation of the benzylidenehydrazonoandrostane derivative 13. The product 14, phosphinom-ethylenehydrazonoandrostane was obtained by the reaction of the derivative 13 with trisdimethylaminophosphine in the presence of dry benzene. The reaction of compound 2b with phenyl isothiocyanate followed by boiling in chloroacetic acid or thioglycolic acid produced the pyrazoloandrostane derivatives 17 and 18 respectively. The biological activity of compounds 6a, 6d, 11, 12, and 15 was evaluated as inhibitor of growth in a human liver carcinoma cell line and doxorubicine was used for comparison. Compounds 15 and 12 showed a higher potency than the other tested compounds.